Recent advances in cryptosporidiosis: the immune response (Q34793048)

4 August 2017

1 reference

title

Recent advances in cryptosporidiosis: the immune response (English)

1 reference

4 August 2017

1 reference

Michael W Riggs

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

published in

Microbes and Infection

1 reference

4 August 2017

volume

4

1 reference

4 August 2017

issue

10

1 reference

4 August 2017

page(s)

1067-1080

1 reference

Innate and cell-mediated immune responses to Cryptosporidium parvum

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Antibody-based immunotherapy of cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Immunological control of Cryptosporidium infection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cryptosporidium: molecular basis of host-parasite interaction

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Human T and B cell immunoreactivity to a recombinant 23-kDa Cryptosporidium parvum antigen

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Fecal antibodies to Cryptosporidium parvum in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Characterization of secretory IgA responses in mice infected with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Role of intraepithelial lymphocytes in mucosal immune responses of mice experimentally infected with Cryptosporidium parvum.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Differential intra-epithelial lymphocyte phenotypes following Cryptosporidium parvum challenge in susceptible and resistant athymic strains of mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Adoptive transfer of immunity with intraepithelial lymphocytes in Cryptosporidium parvum-infected severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Effect of interferon-gamma in experimental Cryptosporidium parvum infection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Kinetics of mucosal ileal gamma-interferon response during cryptosporidiosis in immunocompetent neonatal mice

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Interferon‐γ Expression in Jejunal Biopsies in Experimental Human Cryptosporidiosis Correlates with Prior Sensitization and Control of Oocyst Excretion

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

A Cryptosporidium parvum oocyst low molecular mass fraction evokes a CD4 T-cell-dependent IFN-gamma response in bovine peripheral blood mononuclear cell cultures

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Localization of alpha/beta and gamma/delta T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Lymphocyte Dynamic Patterns in Cattle during a Primary Infection with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Local ileal cytokine responses in cattle during a primary infection with Cryptosporidium parvum.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Pathogenesis of Cryptosporidium parvum infection

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cryptosporidium parvum infection stimulates the secretion of TGF-beta, IL-8 and RANTES by Caco-2 cell line

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Cytotoxic T cells in AIDS colonic cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

Accumulation of mucosal T lymphocytes around epithelial cells after in vitro infection with Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016/S1286-4579(02)01631-3

7 January 2021

10.1016/S1286-4579(02)01631-3

Identifiers

DOI

1 reference

4 August 2017

1 reference